Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery

International Journal of Pharmaceutics

Volumn 309, Issue 1-2, 2006, Pages 71-80

  Bakhbakhi, Yousef ^a   Charpentier, Paul A ^a   Rohani, Sohrab ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Asthma; Beclomethasone dipropionate; GAS; MMAD; Supercritical carbon dioxide

Indexed keywords

ACETONE; ALCOHOL; BECLOMETASONE DIPROPIONATE; METHANOL; SOLVENT; STEROID;

ARTICLE; ASTHMA; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; EXPERIMENTAL STUDY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALER; LASER DIFFRACTION; PARAMETER; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TEMPERATURE ACCLIMATIZATION; X RAY DIFFRACTION;

ACETONE; ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; CARBON DIOXIDE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, SUPERCRITICAL FLUID; CRYSTALLIZATION; PARTICLE SIZE; POWDERS; SOLVENTS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 31144462597     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.11.008     Document Type: Article

References (34)

1. I. Adcock, T. Gilbey, C. Gelder, K. Chung, and P. Barnes Glucocorticoid receptor localization in normal and asthmatic lung Am. J. Respir. Crit. Care Med. 154 1996 771
2. Y. Bakhbakhi, S. Rohani, and P.A. Charpentier Micronization of phenanthrene using the GAS process. Part 1. Experimental study and use of FTIR Ind. Eng. Chem. Res. 44 2005 7337
3. Y. Bakhbakhi, S. Rohani, and P.A. Charpentier Micronization of phenanthrene using the GAS process. Part 2. Theoretical study Ind. Eng. Chem. Res. 44 2005 7345
4. P.J. Barnes, S. Pedersen, and W.W. Busse Efficacy and safety of inhaled corticosteroids. New developments Am. J. Respir. Crit. Care Med. 157 1998 1
5. F. Cansell, B. Chevalier, A. Demourgues, J. Etourneau, C. Even, Y. Garrabos, V. Pessey, S. Petit, A. Tressaud, and F. Weill Supercritical fluid processing: a new route for materials synthesis J. Mater. Chem. 9 1999 67
6. 2 Adv. Mater. 13 2001 1111
7. A.H. de Boer, D. Gjaltema, and P. Hagedoorn Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2. Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers Int. J. Pharm. 138 1996 45
8. P.G. Debenedetti Homogeneous nucleation in supercritical fluids AIChE 36 1990 1289
9. N. Foster, R. Mammucari, F. Dehghani, A. Barrett, K. Bezanehtak, E. Coen, G. Combes, L. Meure, A. Ng, H. Regtop, and A. Tandya Processing pharmaceutical compounds using dense gas technology Ind. Eng. Chem. Res. 42 2003 6476
10. P.M. Gallagher, V.J. Krukonis, and G.D. Botsaris Gas antisolvent recrystallization: application to particle design R. Ramanarayanan W. Kern M. Larson S. Sidkar Particle Design via Crystallization, AIChE Symposium Series 284 1991 96
11. P.M. Gallagher, M.P. Coffey, V.J. Krukonis, and N. Klasutis Gas-antisolvent recrystallization: new process to recrystallize compounds insoluble in supercritical fluids ACS Symposium Series 406 Supercrit. Fluid Sci. Technol. 1989 334
12. Q. Hamid, Y. Song, and T. Kotsimbos Inflammation of small airways in asthma J. Allergy Clin. Immunol. 100 1997 44
13. P. Howarth The relevance of and site of airway inflammation in asthma and targeted aerosol delivery Int. J. Clin. Pract. Suppl. 106 1999 3
14. J. Jung, and M. Perrut Particle design using supercritical fluids: literature and patent survey J. Supercrit. Fluid 20 2001 179
15. V. Krukonis Supercritical fluid nucleation of difficult to comminute solids Proceedings of the AIChE Annual Meeting San Francisco 1984 140f
16. C.L. Leach, P.J. Davidson, B.E. Hasselquist, and R.J. Boudreau Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone Chest 122 2002 510
17. M.A. McHugh, and V.J. Krukonis Supercritical Fluid Extraction: Principles and Practice 1994 Butterworth/Heinemann Boston
18. J. Mitchell, and M. Nagel Particle size analysis of aerosols from medicinal inhalers KONA 22 2004 32
19. M. Muller, U. Meier, A. Kessler, and M. Mazzotti Experimental study of the effect of process parameters in the recrystallization of an organic compound using compressed carbon dioxide as antisolvent Ind. Eng. Chem. Res. 39 2000 2260
20. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma, Update on Selected Topics 2002, National Institutes of Health Publication No. 02-5074. Bethesda, MD, 2003.
21. M. Perrut Supercritical fluid applications: industrial developments and economic issues Ind. Eng. Chem. Res. 39 2000 4532
22. M. Sacchetti, and M. Van Oort Spray-drying and supercritical fluid particle generation techniques A.J. Hickey Inhalation Aerosols: Physical and Biological Basis for Therapy 1996 M. Dekker New York 337
23. B.Yu. Shekunov, and P. York Crystallization processes in pharmaceutical technology and drug delivery design J. Crystal Growth 211 2000 122
24. B. Subramaniam, R.A. Rajewski, and W.K. Snavely Pharmaceutical processing with supercritical carbon dioxide J. Pharm. Sci. 86 1997 885
25. H.S. Tan, and S. Borsadia Particle formation using supercritical fluids: pharmaceutical applicatons Exp. Opin. Ther. Patents 11 2001 861
26. M.P. Timsina, G.P. Martin, C. Marriott, D. Ganderton, and M. Yianneskis Drug delivery to the respiratory tract using dry powder inhalers Int. J. Pharm. 101 1994 1
27. J.W. Tom, and P.G. Debenedetti Particle formation with supercritical fluids - a review J. Aerosol Sci. 22 1991 555
28. J.W. Tom, G.B. Lim, P.G. Debenedetti, and R.K. Prud'homme Applications of SCF in the controlled release of drugs E. Kiran J.F. Brennecke Supercritical Fluid Engineering Science, ACS Symposium Series vol. 514 1993 238
29. C. Vemavarapua, M.J. Mollana, M. Lodayaa, and T.E. Needhamb Design and process aspects of laboratory scale SCF particle formation systems Int. J. Pharm. 292 2005 1
30. H.M. Woods, M.C. Silva, C. Nouvel, K.M. Shakesheff, and S.M. Howdle Materials processing in supercritical carbon dioxide: surfactants, polymers and biomaterials J. Mater. Chem. 14 2004 1663
31. X. Ye, and C.M. Wai Making nanomaterials in supercritical fluids: a review J. Chem. Ed. 80 2003 198
32. P. York Strategies for particle design using supercritical fluid technologies PSIT 2 1999 430
33. P. Zanen, and J.P. Lammers Reducing adverse effect of inhaled fenoterol through optimization of the aerosol formulation J. Aerosol Med. 12 1999 241
34. X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard The use of lactose recrystallized from carbopol gels as a carrier for aerosolized salbutamol sulfate Eur. J. Pharm. Biopharm. 51 2001 55